IDWeek 2014: Study Shows HIV/HCV Coinfected Women Have Lower Bone Density

ART-treated women with HIV/HCV coinfection have greater deficits in some structural bone parameters compared to women with HIV only, HCV only, or neither virus, according to the results of a cross-sectional study presented at IDWeek 2014 last week in Philadelphia. Among women with HCV, bone loss was most profound in those with stage 3-4 liver fibrosis or cirrhosis, which adversely effects bone health.

"Compared to healthy reference participants, the women with HIV/HCV had decreased tibial trabecular volumetric bone mineral and cortical thinning, and significant endocortical bone loss, a pattern observed in other inflammatory diseases," according to Vincent Lo Re of the University of Pennsylvania, who presented the study findings.

Read more...

Labels: , ,